Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Laurence Salin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Laurence Negre-Pages < Laurence Salin < Laurent Brichard  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000334 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000342 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000414 (2008) Olivier Rascol [France] ; Werner Poewe [Autriche] ; Andrew Lees [Royaume-Uni] ; Marina Aristin [France] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Lisa Waldhauser [Allemagne] ; Thomas Schindler [Allemagne]Tesofensine (NS 2330), a Monoamine Reuptake Inhibitor, in Patients With Advanced Parkinson Disease and Motor Fluctuations : The ADVANS Study

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Nervous system diseases
3Parkinson disease
2Dopamine agonist
2Parkinson's disease
2Pramipexole
2Release
2dopamine agonist
1Advanced stage
1Aged
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Benzothiazoles (administration & dosage)
1Benzothiazoles (adverse effects)
1Confidence Intervals
1Delayed-Action Preparations (therapeutic use)
1Dose-Response Relationship, Drug
1Double-Blind Method
1Drug Administration Schedule
1Evaluation
1Female
1Fluctuations
1Human
1Humans
1Male
1Middle Aged
1Parkinson Disease (drug therapy)
1Reuptake inhibitor
1Safety
1Severity of Illness Index
1Tesofensine
1Time Factors
1Treatment
1pramipexole extended release
1pramipexole‐extended release
1switch trial
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Laurence Salin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Laurence Salin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Laurence Salin
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024